Metastatic Osteosarcoma Treatment Market : Business Planning Research
Metastatic Osteosarcoma Treatment Market – Drivers
Increasing drug pipeline for malignant bones and soft tissue (Ewing Sarcoma) cancer is expected to drive growth of metastatic osteosarcoma treatment market. For instance, in 2017, Merck & Co., Inc., studies the effects of Pembrolizumab (MK-3475) in patients with relapsed or metastatic osteosarcoma and reported that these patient are not eligible for curative surgery. Currently, study is in phase II clinical trial and is expected to be marketed in 2023. Moreover, Novartis entered into phase II clinical trials for pazopanib for treatment of metastatic osteosarcoma as of March 2018.
Get The Holistic SAMPLE With Research Methodology: https://www.coherentmarketinsights.com/insight/request-sample/1578
Emerging new therapies for metastatic osteosarcoma treatment will further propel growth of the market. For instance, clinical trials for immunotherapy-based drugs and targeted drug therapy is expected to be a preferred option in the near future, owing to less side-effects. The immune therapy drug called immune checkpoint inhibitors can recognize and attack cancer cells exhibiting better outcomes for other cancer types and also studies have showed it is also effective for osteosarcoma treatment. Moreover, engineered monoclonal antibodies are used to stop cancer growth by hampering new blood vessel formation or to inhibit tumor cells by targeting mTOR protein. For instance, Aadi, LLC studies Nivolumab (Opdivo) in combination with ABI-009 (Nab-rapamycin, the mTOR inhibitor) for potential anti-tumor activity for Ewing Sarcoma. The study is in phase II clinical trial, which is expected to complete by 2020.
Click To Continue Reading On Metastatic Osteosarcoma Treatment Market
You may be interested
Iron Fertilization Creates Short-Lived Carbon Sink in Southern OceanSayali Tribhuvan - June 19, 2018
Researchers discover that iron fertilization creates short-lived carbon sink in the Southern Ocean, according to a study conducted on April 5, 2018. The results of trial conducted…
Dining Out May Increase Level of Harmful Chemicals in Human BodySayali Tribhuvan - June 19, 2018
Researchers reveal that dining out increases exposure to harmful chemicals, according to a study conducted on March 29, 2018. This is the first study, which compares phthalate…
Wood Coatings Market Worldwide Top Players Revenue and Forecasts To 2026Sayali Tribhuvan - June 18, 2018
Wood Coatings Market Report provides an analytical assessment of the prime challenges faced by this Market currently and in the coming years, which helps Market participants in…